Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT01216033 | Exploratory Study of Breast Cancer With ABY025(ABY0125) | completed | Phase 1 / Phase 2 | 7 | Biomedical Radiation SciencesOTHER | 1 | Apr 15, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00304096 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | completed | Phase 1 | 12 | University of VirginiaOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00003184 | Vaccine Therapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 | — | Providence Cancer Center, Earle A. Chiles Research InstituteOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00060372 | Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2013 | clinicaltrials |
| NCT00014430 | Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer | completed | Phase 1 | 13 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Mar 14, 2013 | clinicaltrials |
| NCT00680758 | Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 | 18 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00937482 | Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer | terminated | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00004074 | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT01658358 | ErbB2 Positive Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 15 | China Medical University HospitalOTHER | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00004604 | Biological Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | Duke UniversityOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00959946 | Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | PfizerINDUSTRY | 6 | Feb 22, 2013 | clinicaltrials |
| NCT00721370 | Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer | completed | Phase 1 | 12 | Beth Israel Deaconess Medical CenterOTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT01116297 | Tissue Oxygenation Measurements With Modulated Light (S-FLARE) | completed | Phase 1 | 4 | Beth Israel Deaconess Medical CenterOTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00270907 | CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer | completed | Phase 1 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00004038 | Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00030615 | Decitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00153907 | Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer | completed | Phase 1 | 40 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00055991 | Bexarotene in Preventing Breast Cancer in Women at Genetic Risk | completed | Phase 1 | 87 | Baylor Breast Care CenterOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00039455 | Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00028496 | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00584753 | Molecular Imaging of Breast Cancer With Breast PET/CT | terminated | Phase 1 | 4 | University of California, DavisOTHER | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00372424 | Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive | completed | Phase 1 | 26 | PfizerINDUSTRY | 2 | Dec 28, 2012 | clinicaltrials |
| NCT01301911 | Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast Cancer | terminated | Phase 1 | 26 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00288444 | Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer | terminated | Phase 1 | 38 | Emory UniversityOTHER | 1 | Dec 18, 2012 | clinicaltrials |
| NCT00972413 | Cone Beam Computed Tomography for Breast Imaging(CBCTBI) | completed | Phase 1 | 104 | Koning CorporationINDUSTRY | 1 | Dec 17, 2012 | clinicaltrials |
| NCT00003357 | Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease | completed | Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 13, 2012 | clinicaltrials |
| NCT00506064 | Melatonin Postoperative Sleep Study in Breast Cancer Patients | terminated | Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 5, 2012 | clinicaltrials |
| NCT00128622 | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | H. Kim LyerlyOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT01044485 | Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer(LapDoc) | completed | Phase 1 / Phase 2 | 17 | Centre Georges Francois LeclercOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00614978 | Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer(LAPTEM) | completed | Phase 1 | 18 | Jules Bordet InstituteOTHER | 1 | Sep 19, 2012 | clinicaltrials |
| NCT00028977 | Herbal Therapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 21 | University of California, San FranciscoOTHER | 1 | Sep 17, 2012 | clinicaltrials |
| NCT00068757 | Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | completed | Phase 1 | 23 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 12, 2012 | clinicaltrials |
| NCT01041235 | Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies | completed | Phase 1 | 29 | Azaya Therapeutics, Inc.INDUSTRY | 1 | Sep 6, 2012 | clinicaltrials |
| NCT00645541 | Axillary Reverse Mapping for Invasive Carcinoma of the Breast | completed | Phase 1 | 35 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 2, 2012 | clinicaltrials |
| NCT00002837 | High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer | completed | Phase 1 / Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00516542 | Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 | 6 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 24, 2012 | clinicaltrials |
| NCT00008034 | Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer | completed | Phase 1 | 15 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 18, 2012 | clinicaltrials |
| NCT00788333 | Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer | completed | Phase 1 / Phase 2 | 40 | Bristol-Myers SquibbINDUSTRY | 5 | Jul 13, 2012 | clinicaltrials |
| NCT00529984 | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies(CEA(6D)VRP) | completed | Phase 1 / Phase 2 | 28 | AlphaVax, Inc.INDUSTRY | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00717340 | A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer | completed | Phase 1 | 18 | AVEO Pharmaceuticals, Inc.INDUSTRY | 2 | Jun 28, 2012 | clinicaltrials |
| NCT01333423 | Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC) | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jun 26, 2012 | clinicaltrials |
| NCT00749437 | Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer | completed | Phase 1 | 34 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00412412 | CNF2024 (BIIB021) HER2- (QD) HER2+ (BIW w/Herceptin) PK/PD Study | completed | Phase 1 | 34 | BiogenINDUSTRY | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00006225 | Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00162929 | Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)(AdHERe) | completed | Phase 1 | 5 | Ontario Clinical Oncology Group (OCOG)OTHER | 0 | Jun 4, 2012 | clinicaltrials |
| NCT00307229 | Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1) | completed | Phase 1 | 8 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jun 4, 2012 | clinicaltrials |
| NCT00473005 | Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast | terminated | Phase 1 | 18 | Stanford UniversityOTHER | 1 | May 28, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Apr 26, 2013source: clinicaltrials